ADI-PEG 20 or Placebo Plus Gemcitabine and Docetaxel in Previously Treated Subjects with Leiomyosarcoma (ARGSARC): A Randomized, Double-Blind, Multi-Center Phase 3 Trial
Details
Age
Adult
Locations
University of Colorado Hospital
Principal Investigator
Breelyn Wilky
Study ID
Protocol Number: 23-1728
More information available at ClinicalTrials.gov: NCT05712694
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers